Effects of photodynamic therapy on adhesion molecules and metastasis

Journal of Photochemistry and Photobiology B: Biology

Volumn 52, Issue 1-3, 1999, Pages 65-73

  Rousset, Nathalie ^a   Vonarx, Véronique ^a   Eléouet, Sabine ^a   Carré, Jérome ^a   Kerninon, Erwan ^a   Lajat, Youenn ^a   Patrice, Thierry ^a  

^a CHU de Nantes   (France)

Author keywords

Adhesion molecules; Benzoporphyrin derivative monoacid ring A; Metastasis; Photodynamic therapy; Photofrin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CELL ADHESION MOLECULE; HEMATOPORPHYRIN DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; PHOTOFRIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL DAMAGE; CELL DEATH; CELL MEMBRANE; COLON CANCER; COLORIMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; METASTASIS; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD44; CELL ADHESION; CELL DIVISION; COLONIC NEOPLASMS; DIHEMATOPORPHYRIN ETHER; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; INTERCELLULAR ADHESION MOLECULE-1; NEOPLASM METASTASIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; TUMOR CELLS, CULTURED;

EID: 0033431816     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(99)00104-9     Document Type: Article

References (54)

1. Dougherty T.J. Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 45:1987;879-889.
2. Dougherty T.J., Kaufman J.E., Goldfarb A., Weishaupt K.R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38:1978;2628-2635.
3. Gregorie H.B., Horger E.Q., Ward J.L., Green J.F., Richards T., Robertson H.C., Stevenson T.B. Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann. Surg. 167:1968;820-828.
4. Thomas J.P., Hall R.D., Girotti A.W. Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. Cancer Lett. 35:1987;295-302.
5. Evensen J.F., Sommer S., Moan J., Christensen T. Tumor-localizing and photosensitizing properties of the main components of hematoporphyrin derivative. Cancer Res. 44:1984;482-486.
6. Foultier M.T., Vonarx-Coinsmann V., Cordel S., Combre A., Patrice T. Modulation of colonic cancer adhesiveness by haematoporphyrin derivative therapy. J. Photochem. Photobiol. B: Biol. 23:1994;9-17.
7. Weiss L., Ward P.M. Cell detachment and metastasis. Cancer Metastasis Rev. 2:1983;111-127.
8. Mareel M.M., Van Roy F.M., Bracke M.E. How and when do tumor cells metastasize? Crit. Rev. Oncol. Hematol. 4:1991;559-594.
9. Fidler I.J. Cancer metastasis. Br. Med. Bull. 47:1991;157-177.
10. Tsuchiya Y., Igarashi M., Suzuki R., Kumagai K. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol. 141:1988;699-708.
11. Monsky W.L., Chen W.T. Proteases of cell adhesion proteins in cancers. Semin. Cancer Biol. 4:1993;251-258.
12. Zetter B.R. Adhesion molecules in tumor metastasis. Semin. Cancer Biol. 4:1993;219-229.
13. Evans C.W. Cell adhesion and metastasis. Cell Biol. Intern. Rep. 16:1992;1-10.
14. Rusciano D., Burger M.M. Why do cancer cells metastasize into particular organs? Bioessays. 14:1992;185-194.
15. Giancotti F.G., Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta. 1198:1994;47-64.
16. Lester B.R., McCarthy J.B. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion, and metastasis. Cancer Metastasis Rev. 11:1992;31-44.
17. Dedhar S. Integrins and tumor invasion. Bioessays. 12:1990;583-590.
18. V. Vonarx, N. Rousset, S. Eléouet, J. Carré, Y. Heuzé, Y. Lajat, T. Patrice, Cell distribution and phototoxicity of benzoporphyrin derivative and photofrin, J. Photochem. Photobiol. B: Biol., submitted for publication.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J. Immunol. Methods. 65:1983;55-63.
20. Gollnick S.O., Liu X., Owczarczak B., Musser D.A., Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57:1997;3904-3909.
21. Qin B., Selman S.H., Payne K.M., Keck R.W., Metzger D.W. Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation. Transplantation. 56:1993;1481-1486.
22. Y. Hayata, C. Konaka, Photodynamic therapy of neoplastic disease, in: D. Kessel (Ed.), Photodynamic Therapy of Neoplastic Diseases, vol. 1, CRC Press, Boca Raton, FL, 1990, pp. 43-64.
23. McCaughan J.S. Photodynamic therapy of skin and oesophageal cancers. Cancer Invest. 83:1990;407-416.
24. Buchanan R.B., Carruth J.A.S., McKenzie A.L., Williams S.R. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur. J. Surg. Oncol. 15:1989;400-406.
25. Kreimer-Birnbaum M. Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Semin. Hematol. 26:1989;157-173.
26. Richter A.M., Waterfield E., Jain A.K., Sternberg E.D., Dolphin D., Levy J.G. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem. Photobiol. 52:1990;495-500.
27. Richter A.M., Waterfield E., Jain A.K., Allison B., Sternberg E.D., Dolphin D., Levy J.G. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br. J. Cancer. 63:1991;87-93.
28. Jamieson C.H.M., McDonald W.N., Levy J.G. Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells. Leukemia Res. 14:1990;209-219.
29. Neyndorff H.C., Artel D.L., Tufaro F., Levy J.G. Development of a model to demonstrate photosensitiser-mediated viral inactivation in blood. Transfusion. 30:1990;485-490.
30. Vonarx V., Foultier M.T., Xavier de Brito L., Anasagasti L., Morlet L., Patrice T. Photodynamic therapy decreases cancer colonic cell adhesiveness and metastatic potential. Res. Exp. Med. 195:1995;101-116.
31. Lanzafame R.J., Rogers D.W., Naim J.O., Herrera H.R., Hinshaw R. Effect of hematoporphyrin derivative on oestrogen receptors in the dimethylbenzanthracene-mammary tumor model. Laser Surg. Med. 6:1987;543-545.
32. Davies C.A. Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment. Br. J. Cancer. 58:1988;306-313.
33. Dubbelman T.M.A.R., Van Stevenick J. Photodynamic effects of hematoporphyrin-derivative on transmembrane transport systems of murine L929 fibroblasts. Biochim. Biophys. Acta. 771:1984;201-207.
34. Hill S.A., Denekamp J. Does local tumor heating in mice influence metastatic spread? Br. J. Radiol. 55:1982;441-451.
35. Stamenkovic I., Aruffo A., Amiot M., Pesando J.M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO J. 10:1991;343-348.
36. Alho A.M., Underhill C.B. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J. Cell Biol. 108:1989;1557-1565.
37. Gunther U., Hofmann M., Rudy W. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
38. Hofmann M., Rudy W., Zoller M. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 51:1991;5292-5297.
39. Castella E.M., Ariza A., Pellicer I., Fernandez-Vasalo A., Ojanguren I. Differential expression of CD44V6 in metastases of intestinal and diffuse types of gastric carcinoma. J. Clin. Pathol. 51:1998;134-137.
40. Maurer C.A., Friess H., Kretschmann B., Wildi S., Muller C., Graber H., Schilling M., Buchler M.W. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int. J. Cancer. 79:1998;76-81.
41. Blom D.-J.R., Schuitmaker H.J., de Waard-Siebinga I., Dubbelman T.M.A.R., Jager M.J. Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy. Cancer Lett. 112:1997;239-243.
42. Martin F., Caignard A., Jeannin J.F., Leclerc A., Martin M. Selection by trypsin of two sublines of rat colon cancer forming progressive or regressive tumors. Int. J. Cancer. 32:1983;623-627.
43. Berrada A., Vavasseur F., Le Pendu J., Meflah K. Correlation between cell surface oligosaccharide and tissue target-selective adhesion of two rat adenocarcinoma cell lines. Invasion Metastasis. 10:1990;352-371.
44. Canti G., Lattuada D., Nicolin A., Taroni P., Valentini G., Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs. 5:1994;443-447.
45. Jolles C.J., Ott M.J., Straight R.C., Lynch D.H. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am. J. Obstet. Gynecol. 158:1988;1446-1453.
46. Krutmann J., Athar M., Mendel D.B., Khan I.U., Guyre P.M., Mukhtar H., Elmets C.A. Inhibition of the high affinity Fc receptor (FcRI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J. Biol. Chem. 264:1989;11407-11413.
47. Weg-Remers S., Anders M., von Lampe B., Riecken E.O., Schuder G., Feifel G., Zeitz M., Stallmach A. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas. Eur. J. Cancer. 34:1998;1607-1611.
48. Tokumo K., Kodama J., Seki N., Miyagi Y., Yoshinouchi M., Kudo T. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Eur. J. Cancer. 34:1998;2107-2111.
49. Günthert A.R., Sträter J., Von Reyher U., Henne C., Joos S., Koretz K., Moldenhauer G., Krammer P.H., Möller P. Early detachment of colon carcinoma cells during CD95 (APO-1/Fas)-mediated apoptosis: I. De-adhesion from hyaluronate by shedding of CD44. J. Cell Biol. 134:1996;1089-1096.
50. Kessel D., Luo Y. Delayed oxidative photodamage induced by photodynamic therapy. Photochem. Photobiol. 64:1996;601-604.
51. Granville D.J., Jiang H., An M.T., McManus B.M., Hunt D.W. Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett. 422:1998;151-154.
52. Granville D.J., Levy J.G., Hunt D.W. Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells. Photochem. Photobiol. 67:1998;358-362.
53. Dellinger M. Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem. Photobiol. 64:1996;182-187.
54. 2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells. Cancer Lett. 128:1998;205-210.